1. Home
  2. VPG vs PCRX Comparison

VPG vs PCRX Comparison

Compare VPG & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vishay Precision Group Inc.

VPG

Vishay Precision Group Inc.

N/A

Current Price

$60.05

Market Cap

968.7M

Sector

Technology

ML Signal

N/A

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

N/A

Current Price

$26.31

Market Cap

949.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VPG
PCRX
Founded
2009
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
968.7M
949.9M
IPO Year
2010
2010

Fundamental Metrics

Financial Performance
Metric
VPG
PCRX
Price
$60.05
$26.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$53.50
$30.25
AVG Volume (30 Days)
577.4K
556.1K
Earning Date
05-12-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.44
EPS
N/A
0.19
Revenue
$307,202,000.00
$541,533,000.00
Revenue This Year
$7.21
$6.78
Revenue Next Year
$6.92
$8.54
P/E Ratio
N/A
$139.32
Revenue Growth
0.22
26.04
52 Week Low
$27.74
$18.80
52 Week High
$151.78
$27.66

Technical Indicators

Market Signals
Indicator
VPG
PCRX
Relative Strength Index (RSI) 35.63 63.37
Support Level $38.13 $22.03
Resistance Level $76.58 $26.94
Average True Range (ATR) 3.70 0.65
MACD 0.94 0.27
Stochastic Oscillator 6.20 100.00

Price Performance

Historical Comparison
VPG
PCRX

About VPG Vishay Precision Group Inc.

Vishay Precision Group Inc manufactures and markets sensors and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: